Lung-Spleen Qi Deficiency Syndrome: Clinical Trials

1 trial for Lung-Spleen Qi Deficiency Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1

Follow Lung-Spleen Qi Deficiency Syndrome: new trials by email Literature Review of Lung-Spleen Qi Deficiency Syndrome trials Research Report on Lung-Spleen Qi Deficiency Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency
Qiling Yiqi Tablets plus ART, Antiretroviral Therapy (ART) - HIV-1 Infection, Acquired Immunodeficiency Syndrome
Not applicableNot yet recruitingBeijing University of Chinese Medicine2402026-08-012026-07-13

Narrower conditions

Acquired Immunodeficiency Syndrome (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

Antiretroviral Therapy, Highly Active (1)

Sponsors

Beijing University of Chinese Medicine (1)

Countries

China (1)